Starting on:
Aug 11, 2020
Ending on:
Jul 10, 2020
Moderator(s):
Venue:
Virtual- International Cancer Institute
Max Credits:
5 Points
Provider:
International Cancer Institute
Claim Points
Aug 11, 2020
Ending on:
Jul 10, 2020
Moderator(s):
Virtual- International Cancer Institute
Max Credits:
5 Points
Provider:
International Cancer Institute
Claim Points
INTERNATIONAL CANCER INSTITUTE PROSTATE CANCER PRECEPTORSHIP
Starting on:
Aug 11, 2020 4:00 PM
Aug 11, 2020 4:00 PM
Ending on:
Jul 10, 2020 5:30 PM
Jul 10, 2020 5:30 PM
Venue:
Virtual- International Cancer Institute
Virtual- International Cancer Institute
Description
Multidisciplinary management, standards of care, optimal diagnostics, therapies and future perspectives in the care of Prostate Cancer patients in sub-Saharan Africa.
Objectives
At the end of this educational activity, participants should be able to:
1. Understand the Epidemiology of Prostate Cancer (Global)
2. To understand the role of screening for prostate cancer, including the evidence for and against the use of prostate-specific antigen (PSA) screening and the practical indications of serum PSA measurement in different clinical settings
3. recognize the role of pathological diagnosis, histologic grading, Gleason system, staging and prognostic factors in prostate cancer.
4. To understand the role of Surgery in the management of localized prostate cancer
5. To understand the role of radiotherapy in the management of localized prostate cancer
6. understand the management options for hormone sensitive metastatic prostate cancer
7. To understand the definition of castration-resistant prostate cancer (CRPC) and appreciate the novel therapies, their use and side effects profile in m-CRPC.
8. Discuss treatment options for patients with advanced prostate cancer, including secondary hormonal therapy, chemotherapy, immunotherapy, and radioisotope therapy
9. Understanding of how and when to use bone-targeted therapies and of the prevention and treatment of osteonecrosis of the jaw
10. To understand the role of multidisciplinary team in prostate cancer management
11. To understand the role of Palliative, supportive and survivorship care in prostate cancer management
12. Ability to diagnose and manage spinal cord compression, one of the most devastating complications of metastatic prostate cancer
13. To discuss clinical cases between faculty and participants
Presenters
-
Prof.
Chite Asirwa
Consultant Physician, Medical Oncologist & Hematologst Executive Director/CEO: Inernational Cancer Institute
ICI -
Prof.
Dinesh Pendharkar
Consultant Oncologist
-
Dr.
Kibet Keitany
Anatomic Pathologist
-
Dr.
Verna Vanderpuye
Consultant Radiation Oncologist
-
Dr.
Helena Musau
Clinical Oncologist
Meru County Referral Hospital -
Dr.
Abdu Yesufe
Clinical Oncologist
-
Dr.
Irene Weru
Oncology Pharmacist
-
Dr.
Sitna Mwanzi
Medical Oncologist
-
Dr.
Achille Manirakiza
Clinical Oncologist
-
Dr.
Zipporah Ali
Palliative Care Specialist